CRT Inc.

CRT Inc, the US subsidiary of Cancer Research Technology Ltd, was established in 2006 and is located in Cambridge MA. CRT Inc works with CRT Ltd to license technologies arising from Cancer Research UK funding and also provides oncology-focused technology transfer and development support to leading US not-for-profit research institutions.

Dr Larry Steranka, CRT Inc's Managing Director, was previously the Executive Director of Brandeis University's Office of Technology Licensing, and immediately before that, an Associate Director for Licensing at Harvard University's Office of Technology and Trademark Licensing. Dr Steranka has also held senior positions within major pharmaceutical and biotechnology companies.

Contact: Corinne Carroll on ccarroll@cancertechnology.com